G

Global Health Ltd
NSE:MEDANTA

Watchlist Manager
Global Health Ltd
NSE:MEDANTA
Watchlist
Price: 1 161.7 INR -0.74% Market Closed
Market Cap: 312.1B INR

Global Health Ltd
Cash & Cash Equivalents

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Global Health Ltd
Cash & Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
G
Global Health Ltd
NSE:MEDANTA
Cash & Cash Equivalents
₹2.3B
CAGR 3-Years
24%
CAGR 5-Years
9%
CAGR 10-Years
N/A
Krishna Institute of Medical Sciences Ltd
NSE:KIMS
Cash & Cash Equivalents
₹560m
CAGR 3-Years
30%
CAGR 5-Years
7%
CAGR 10-Years
N/A
Apollo Hospitals Enterprise Ltd
NSE:APOLLOHOSP
Cash & Cash Equivalents
₹5.8B
CAGR 3-Years
-18%
CAGR 5-Years
9%
CAGR 10-Years
7%
F
Fortis Healthcare Ltd
NSE:FORTIS
Cash & Cash Equivalents
₹799.2m
CAGR 3-Years
-39%
CAGR 5-Years
-23%
CAGR 10-Years
-14%
Max Healthcare Institute Ltd
NSE:MAXHEALTH
Cash & Cash Equivalents
₹5B
CAGR 3-Years
-16%
CAGR 5-Years
4%
CAGR 10-Years
N/A
Narayana Hrudayalaya Ltd
NSE:NH
Cash & Cash Equivalents
₹4.6B
CAGR 3-Years
18%
CAGR 5-Years
36%
CAGR 10-Years
N/A
No Stocks Found

Global Health Ltd
Glance View

Market Cap
312B INR
Industry
Health Care

Global Health Ltd., a growing name in the healthcare sector, has carved out a niche in advancing modern medical practices across a range of facilities. With a network of multi-specialty hospitals, the company has positioned itself as a formidable provider of comprehensive healthcare solutions. These hospitals span numerous locations, utilizing cutting-edge technology and highly skilled medical professionals to offer services that range from routine wellness care to specialized treatments. Global Health Ltd.'s holistic approach ensures not only treatment of diseases but also focuses on preventive measures and long-term health improvement. This emphasis on varied healthcare services allows the company to reach a broad audience, contributing to its steady revenue stream. Revenue generation for Global Health Ltd. primarily stems from patient fees, which include costs for inpatient and outpatient services, diagnostics, surgical procedures, and other medical services. Additionally, the company leverages partnerships with insurance providers, ensuring a wider reach and facilitating payments through insurance claims. By maintaining strategic alliances and continuously upgrading its healthcare offerings, Global Health Ltd. amplifies its market presence. Through innovation and an unwavering commitment to quality care, the company not only bolsters its financial strength but also enhances its reputation as a leader in the healthcare industry, adeptly navigating the ever-evolving demands of the sector.

MEDANTA Intrinsic Value
978.77 INR
Overvaluation 16%
Intrinsic Value
Price
G

See Also

What is Global Health Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
2.3B INR

Based on the financial report for Mar 31, 2025, Global Health Ltd's Cash & Cash Equivalents amounts to 2.3B INR.

What is Global Health Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
9%

Over the last year, the Cash & Cash Equivalents growth was -46%. The average annual Cash & Cash Equivalents growth rates for Global Health Ltd have been 24% over the past three years , 9% over the past five years .

Back to Top